Hyperlipoproteinemia Type II

A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).

Also Known As:

Familial Hypercholesterolemia; Hypercholesterolemia, Familial; Apolipoprotein B-100, Familial Ligand-Defective; Familial Combined Hyperlipoproteinemia; Hyper-Low Density Lipoproteinemia; Hypercholesterolemia, Autosomal Dominant; Hyperlipoproteinemia Type IIa; Hyperlipoproteinemia Type IIb; LDL Receptor Disorder; Apolipoprotein B 100, Familial Ligand Defective; Autosomal Dominant Hypercholesterolemia; Combined Hyperlipoproteinemia, Familial; Essential Hypercholesterolemia; Essential Hypercholesterolemias; Familial Hypercholesterolemias; Hyper Low Density Lipoproteinemia; Hyper-Low Density Lipoproteinemias; Hyperbetalipoproteinemias; Hypercholesterolemias, Essential; Hypercholesterolemias, Familial; Hyperlipoproteinemia, Familial Combined; Lipoproteinemia, Hyper-Low Density; Lipoproteinemias, Hyper-Low Density; Hyperbetalipoproteinemia; Hypercholesterolemia, Essential

-

Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 449

-

Inborn Genetic Diseases: 578

-

Inborn Errors Metabolism: 434

-

Inborn Errors Lipid Metabolism

*

Hyperlipoproteinemia Type II: 2116

-

Nutritional and Metabolic Diseases

-

Metabolic Diseases: 1406

-

Inborn Errors Metabolism: 434

-

Inborn Errors Lipid Metabolism

*

Hyperlipoproteinemia Type II: 2116

-

Lipid Metabolism Disorders: 92

-

Dyslipidemias: 4230

-

Hyperlipidemias: 6937

-

Hyperlipoproteinemias: 1561

*

Hyperlipoproteinemia Type II: 2116

M A Lasuncion Selected Research

Articles by Research Topic

Disease

Drug/Important Bio-Agent (IBA)